Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.
Pancreatic proteases in the duodenum inhibit the release of cholecystokinin (CCK) and thus exert feedback control of pancreatic exocrine secretion. Exclusion of proteases from the duodenum either by the diversion of bile-pancreatic juice or by the addition of protease inhibitors stimulates exocrine...
保存先:
| 出版年: | Proc Natl Acad Sci U S A |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
1996
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC38851/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8755579/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.15.7927 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|